Scarica l'app Stockscreener
2.72
0.00%
0.00
Precedente Chiudi:
$2.72
Aprire:
$2.8
Volume 24 ore:
336.16K
Relative Volume:
3.08
Capitalizzazione di mercato:
$6.43M
Reddito:
$9.26M
Utile/perdita netta:
$-941.60K
Rapporto P/E:
-37.78
EPS:
-0.072
Flusso di cassa netto:
$-2.65M
1 W Prestazione:
-11.31%
1M Prestazione:
-34.30%
6M Prestazione:
-40.22%
1 anno Prestazione:
-32.00%
Intervallo 1D:
$2.6001
$2.9594
Intervallo di 1 settimana:
$2.6001
$3.5194
Portata 52W:
$2.0068
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Nome
Bionexus Gene Lab Corp
Settore
Industria
Telefono
1-307-241-6898
Indirizzo
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Confronta BGLC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
4.25 | 6.26B | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
9.115 | 481.52M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.25 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
2.87 | 264.10M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DWLD
Davis Select Worldwide ETF
|
47.07 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Borsa (BGLC) Ultime notizie
BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market - marketscreener.com
Analyst Calls: Is BioNexus Gene Lab Corp a strong candidate for buy and hold2025 Price Targets & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Block Trades: Will BioNexus Gene Lab Corp outperform its industry peersJuly 2025 Outlook & Fast Entry Momentum Alerts - baoquankhu1.vn
BioNexus Gene Lab stockholders back governance and incentive plan - MSN
Whale Trades: Can BioNexus Gene Lab Corp be the next market leaderMarket Performance Summary & Entry Point Confirmation Signals - baoquankhu1.vn
BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update - Defense World
Bearish Setup: Will BioNexus Gene Lab Corp outperform its industry peersJuly 2025 Summary & Consistent Return Investment Signals - baoquankhu1.vn
New Highs: Will QCR Holdings Inc stock recover after earningsDay Trade & Smart Swing Trading Alerts - baoquankhu1.vn
Why BioNexus Gene Lab Corp. stock is trending among retail tradersJuly 2025 Rallies & Precise Buy Zone Identification - Улправда
Insider Trends: Can BioNexus Gene Lab Corp. stock deliver sustainable ROEJuly 2025 Levels & Community Driven Trade Alerts - Улправда
How BioNexus Gene Lab Corp. stock reacts to job market dataJuly 2025 Intraday Action & Verified Stock Trade Ideas - Улправда
Can BioNexus Gene Lab Corp. stock deliver sustainable ROEJuly 2025 Levels & Community Driven Trade Alerts - ulpravda.ru
Why BioNexus Gene Lab Corp. stock is recommended by analystsJuly 2025 Chart Watch & AI Powered Market Entry Ideas - Улправда
Downgrade Watch: Can BioNexus Gene Lab Corp stock resist market sell offsShort Setup & Technical Pattern Alert System - moha.gov.vn
BioNexus Gene Lab Stockholders Back Governance and Incentive Plan - The Globe and Mail
BioNexus Gene Lab shareholders approve board, equity plan, and auditor at annual meeting - Investing.com Australia
BioNexus Gene Lab shareholders approve board, equity plan, and auditor at annual meeting By Investing.com - Investing.com South Africa
How supply chain issues affect BioNexus Gene Lab Corp. stockMarket Insider Reports & Capitalize On Fast Trends - bollywoodhelpline.com
BioNexus Gene Lab (NASDAQ:BGLC) Shares Down 0.2% – Should You Sell? - Defense World
BioNexus Gene Lab Shares Surge on Strategic MRD Testing Partnership - MSN
BioNexus Chemrex leadership resignations prompt governance review - The Globe and Mail
Bionexus Gene Lab CorpMatthew L. Barsing appointed as chairman of Chemrex boardSEC filing - marketscreener.com
BioNexus Gene Lab Corp Evaluates CDMO Expansion - TradingView — Track All Markets
Inflation Data: Is BioNexus Gene Lab Corp. stock attractive after correctionQuarterly Portfolio Review & Daily Growth Stock Tips - DonanımHaber
What margin trends mean for BioNexus Gene Lab Corp. stockPortfolio Value Summary & Real-Time Volume Spike Alerts - DonanımHaber
Will BioNexus Gene Lab Corp. stock gain from lower inflation2025 Trade Ideas & Expert Approved Trade Ideas - DonanımHaber
Is BioNexus Gene Lab Corp. stock attractive after correction2025 Key Highlights & Growth Focused Entry Reports - DonanımHaber
Can BioNexus Gene Lab Corp. stock maintain growth trajectory2025 Market WrapUp & Stepwise Trade Execution Plans - Улправда
Bionexus Gene Lab completes investment in Fidelion Diagnostics - MSN
Analysis Recap: How BioNexus Gene Lab Corp stock valuations compare to rivalsStop Loss & Target Return Focused Stock Picks - moha.gov.vn
BioNexus Gene Lab stock soars after strategic MRD testing agreements By Investing.com - Investing.com Nigeria
Is BioNexus Gene Lab Corp. stock safe for conservative investorsWeekly Profit Summary & Stepwise Trade Execution Plans - Newser
12 Industrials Stocks Moving In Thursday's Pre-Market Session - Benzinga
A Look at BioNexus Gene Lab Corp (BGLC) Shares in the Recent Past Indicates Growth - setenews.com
Blue Gold Sets $15 Million Gold Trading Facility - marketscreener.com
Bionexus Gene Lab completes strategic investment in Fidelion Diagnostics, secures 15% equity stake in global AI Oncologic platform - MarketScreener
BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics - Investing.com
BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics By Investing.com - Investing.com South Africa
BioNexus Gene Lab Corp. Completes Strategic Transaction with Fidelion Diagnostics, Securing Exclusive Rights for VitaGuard™ in Southeast Asia - Quiver Quantitative
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard - marketscreener.com
BioNexus Gene Lab (NASDAQ: BGLC) acquires 15% Fidelion stake, VitaGuard ASEAN rights - Stock Titan
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™ - The Manila Times
BioNexus Gene Lab secures $500 million equity purchase agreement By Investing.com - Investing.com Nigeria
BioNexus Gene Lab stock falls after securing $500M equity facility - Investing.com Nigeria
BioNexus Gene Lab stock falls after securing $500M equity facility By Investing.com - Investing.com South Africa
BioNexus Gene Lab Shares Jump After Securing $500 Million Equity Facility - MSN
Bionexus Gene Lab secures $500M equity facility from ARC Group - TipRanks
Bionexus Gene Lab Corp Azioni (BGLC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.33%
3.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):